Efficacy and Safety of HS-20094 in Patients with Type 2 Diabetes-A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

被引：0
|
作者：
Liu, Lin
Shi, Xiaoxia
He, Fei
Cheng, Zhifeng
Song, Weihong
Wang, Zhongjing
Cui, Yimin
Zhang, Junqing
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-733-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
733-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
    Nobuya Inagaki
    Shin-ichi Harashima
    Nobuko Maruyama
    Yutaka Kawaguchi
    Maki Goda
    Hiroaki Iijima
    Cardiovascular Diabetology, 15
  • [32] Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study
    Inagaki, N.
    Kondo, K.
    Yoshinari, T.
    Maruyama, N.
    Susuta, Y.
    Kuki, H.
    DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1136 - 1145
  • [33] Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
    Inagaki, Nobuya
    Harashima, Shin-ichi
    Maruyama, Nobuko
    Kawaguchi, Yutaka
    Goda, Maki
    Iijima, Hiroaki
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [34] Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
    Taskinen, M. -R.
    Rosenstock, J.
    Tamminen, I.
    Kubiak, R.
    Patel, S.
    Dugi, K. A.
    Woerle, H. -J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (01): : 65 - 74
  • [35] Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
    Camm, A. John
    Toft, Egon
    Torp-Pedersen, Christian
    Vijayaraman, Pugazhendhi
    Juul-Moller, Steen
    Ip, John
    Beatch, Gregory N.
    Dickinson, Garth
    Wyse, D. George
    EUROPACE, 2012, 14 (06): : 804 - 809
  • [36] Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
    Vehreschild, Maria J. G. T.
    Atanasov, Petar
    Yurko, Kateryna
    Oancea, Cristian
    Popov, Georgi
    Smesnoi, Valentina
    Placinta, Gheorghe
    Kohlhof, Hella
    Vitt, Daniel
    Peelen, Evelyn
    Mihajlovic, Jelena
    Muehler, Andreas R.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (06) : 2159 - 2176
  • [37] Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
    Maria J. G. T. Vehreschild
    Petar Atanasov
    Kateryna Yurko
    Cristian Oancea
    Georgi Popov
    Valentina Smesnoi
    Gheorghe Placinta
    Hella Kohlhof
    Daniel Vitt
    Evelyn Peelen
    Jelena Mihajlović
    Andreas R. Muehler
    Infectious Diseases and Therapy, 2022, 11 : 2159 - 2176
  • [38] Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial
    Seol-Hee, Baek
    Je-Young, Shin
    Sung-Yeon, Sohn
    Kee, Hong Park
    Jun-Soon, Kim
    Bongjae, Kim
    So, Hyun Ahn
    Kyomin, Choi
    Yoon-Ho, Hong
    Sung, Jung-Joon
    PARKINSONISM & RELATED DISORDERS, 2022, 103 : 1 - 6
  • [39] Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: a double-blind, placebo-controlled, clinical trial
    Kaku, Kohei
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (05) : 1111 - 1119
  • [40] Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double-blind, placebo-controlled, Phase 3 trial
    Ji, Linong
    Jiang, Xiaozhen
    Hao, Qingshun
    Cheng, Zhifeng
    Wang, Kun
    Pang, Shuguang
    Liu, Meiying
    Guo, Yushan
    Chen, Xiaowen
    Su, Xiuhai
    Ning, Tao
    Liu, Jie
    Bian, Fang
    Li, Yulan
    Zhang, Zhinong
    Song, Weihong
    Sun, Jingfang
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1229 - 1240
12345